Prelude Therapeutics Incorporated

NASDAQ:PRLD

1.19 (USD) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 0003.4240000000000000000000
Kosten van de omzet 00.4520.4260.3310.2790.7230.710.7990.7760.7490.7180.690.6220.4890.44200000000
Brutowinst 0-0.452-0.4263.093-0.279-0.723-0.71-0.799-0.776-0.749-0.718-0.69-0.622-0.489-0.44200000000
Brutowinstmarge 0000.9030000000000000000000
Onderzoek- en ontwikkelingskosten 29.45729.50927.40930.33226.26124.96621.83425.86922.88921.3122.82125.17822.72122.40916.4714.57215.2939.7768.5368.8495.494.974.97
Algemene en administratieve kosten 7.9197.6556.9347.0477.1247.4327.2817.5167.5178.1517.4677.8328.1155.5135.4974.8742.8511.661.2011.2461.3940.5950.595
Verkoop- en marketingkosten 0-0.452000000000000000000000
Verkoop-, algemene en administratieve kosten 7.9197.2036.9347.0477.1247.4327.2817.5167.5178.1517.4677.8328.1155.5135.4974.8742.8511.661.2011.2461.3940.5950.595
Overige kosten 02.4242.9124.3042.7771.9671.3974.7440.4482.0870.8230.1680.1491.0570.6670.1961.3840.0280.2260.0560.1500
Bedrijfskosten 37.37636.71234.34337.37933.38532.39829.11533.38530.40629.46130.28833.0130.83627.92221.96719.44618.14411.4369.73710.0956.8845.3995.399
Bedrijfsresultaat -34.376-37.164-34.343-37.379-33.385-32.398-29.115-33.385-30.406-29.461-30.288-33.01-30.836-27.922-21.967-19.446-18.144-11.436-9.737-10.095-6.884-5.565-5.565
Bedrijfsresultaat ratio 000-10.9170000000000000000000
Totaal overige inkomsten en kosten netto 2.1052.4242.9124.3042.7771.9671.3974.7440.4482.0870.8230.1680.1491.0570.6670.1961.3840.0280.2260.0560.150.1670.167
Inkomen voor belasting -32.271-34.74-31.431-33.075-30.608-30.431-27.718-28.641-29.958-27.374-29.465-32.842-30.687-26.865-21.3-19.25-16.76-11.408-9.511-10.039-6.734-5.399-5.399
Inkomen voor belasting ratio 000-9.660000000000000000000
Belastingkosten 00-0.4261.676-0.2790.239-1.397-7.654-0.448-2.087-0.823-0.168-0.356-0.29-0.28200000000
Nettowinst -32.271-34.74-31.431-33.075-30.608-30.431-26.321-20.987-29.51-25.287-28.642-32.842-30.687-26.865-21.3-19.25-16.76-11.408-9.511-10.039-6.734-5.399-5.399
Nettowinstmarge 000-9.660000000000000000000
WPA (Winst Per Aandeel) -0.43-0.46-0.42-0.48-0.45-0.54-0.55-0.44-0.62-0.53-0.61-0.71-0.66-0.58-0.47-0.51-0.44-0.3-0.29-0.31-0.21-3.43-3.43
Verwaterde WPA -0.43-0.46-0.42-0.48-0.45-0.54-0.55-0.44-0.62-0.53-0.61-0.71-0.66-0.58-0.47-0.51-0.44-0.3-0.29-0.31-0.21-3.42-3.42
EBITDA -34.376-36.712-34.343-37.048-33.385-32.117-28.837-33.023-30.069-29.143-29.981-32.72-30.57-27.723-21.807-19.313-18.002-11.301-9.605-9.967-6.785-5.488-5.488
EBITDA ratio 000-10.820000000000000000000